The Institute of Cancer Research, Belmont, Surrey, UK.
Bioorg Med Chem. 2011 Jan 15;19(2):836-51. doi: 10.1016/j.bmc.2010.12.006. Epub 2010 Dec 9.
Two classes of trisubstituted pyrimidines related to PI-103 1 have been prepared and their inhibitory activities against phosphatidylinositol 3-kinase (PI3K) p110α were determined. From those with direct 6-aryl substitution compound 11a was the most potent inhibitor with an IC₅₀ value of 62 nM, and showed similar activity against other class 1a PI3K isoforms tested, p110β and p110γ. When a linking chain was introduced, as in the second exemplified class, compound 15f inhibited p110α with IC₅₀ 142 nM, and showed greater selectivity towards p110α. Compounds of both classes showed promising inhibition of cellular proliferation in IGROV-1 ovarian cancer cells. Among compounds designed to replace the 3-phenolic motif with structural isosteres, analogues incorporating a 4-indazolyl group possessed enzyme and cellular activities comparable to the parent phenols.
已经制备了两类与 PI-103 1 相关的三取代嘧啶,并测定了它们对磷脂酰肌醇 3-激酶 (PI3K) p110α 的抑制活性。在具有直接 6-芳基取代的化合物中,11a 是最有效的抑制剂,IC₅₀ 值为 62 nM,并且对其他测试的 1a 类 PI3K 同工酶,p110β 和 p110γ,表现出相似的活性。当引入连接链时,如在第二类中举例说明的那样,化合物 15f 以 IC₅₀ 142 nM 抑制 p110α,并且对 p110α 表现出更大的选择性。这两类化合物在 IGROV-1 卵巢癌细胞中均显示出有希望的细胞增殖抑制作用。在所设计的用结构类似物替代 3-酚基模体的化合物中,含有 4-吲唑基的类似物具有与母体酚相当的酶和细胞活性。